Velia is a transformative biotech company with the ambitious goal of harnessing the therapeutic potential of a novel class of human peptides. Building upon the founders’ seminal work, the Velia team will construct and deploy a novel target discovery pipeline that integrates computational science, high throughput profiling, functional genomics, and human clinical data.